Review highlights escalating antibiotic resistance in Helicobacter pylori infections, suggesting that susceptibility testing and novel combinations are essential for effective management.
The dramatic global rise in H. pylori antibiotic resistance requires an urgent revision of current management strategies. Possible solutions include AST-based selection of effective treatment regimens, identification of novel combinations of existing drugs and exploration of novel drugs.
No takes yet. Share an insight, caveat, or question.
Schulz et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: